Kala Pharmaceuticals, Inc. (KALA): Price and Financial Metrics
Kala Pharmaceuticals, Inc. (KALA)
Today's Latest Price: $7.18 USD
Updated Nov 24 4:00pm
Add KALA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
KALA Stock Summary
- Kala Pharmaceuticals Inc's stock had its IPO on July 20, 2017, making it an older stock than just 11.22% of US equities in our set.
- With a price/sales ratio of 79.29, Kala Pharmaceuticals Inc has a higher such ratio than 96.62% of stocks in our set.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for KALA comes in at -34.76% -- higher than that of just 10.26% of stocks in our set.
- Stocks that are quantitatively similar to KALA, based on their financial statements, market capitalization, and price volatility, are VIVE, QUOT, TWOU, CNTG, and CTSO.
- KALA's SEC filings can be seen here. And to visit Kala Pharmaceuticals Inc's official web site, go to www.kalarx.com.
KALA Stock Price Chart Interactive Chart >
KALA Price/Volume Stats
| Current price | $7.18 | 52-week high | $14.68 |
| Prev. close | $7.37 | 52-week low | $3.60 |
| Day low | $7.04 | Volume | 1,382,500 |
| Day high | $7.47 | Avg. volume | 1,214,759 |
| 50-day MA | $7.75 | Dividend yield | N/A |
| 200-day MA | $9.15 | Market Cap | 402.62M |
Kala Pharmaceuticals, Inc. (KALA) Company Bio
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles technology. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was founded in 2009 and is based in Waltham, Massachusetts.
Loading social stream, please wait...